A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02020434

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:59.623102+00:00

Published At

2018-03-05T00:00:00+00:00

Record Updated At

2018-03-05

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Subjects With Varying Degrees of Renal Insufficiency and", "Subjects With Normal Renal Function"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-03-05"

protocolSection.identificationModule.nctId

"NCT02020434"

protocolSection.identificationModule.officialTitle

"A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance\u2122 (RPX2014/RPX7009) in Subjects With Renal Insufficiency"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Subjects With Varying Degrees of Renal Insufficiency and (protocolSection.conditionsModule.conditions)
• Subjects With Normal Renal Function (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.